Click Holdings Limited (NASDAQ:CLIK) Sees Significant Decrease in Short Interest

Click Holdings Limited (NASDAQ:CLIK) was the recipient of a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 2,237 shares, a decrease of 35.1% from the January 15th total of 3,446 shares. Based on an average daily volume of 6,248 shares, the short-interest ratio is presently 0.4 days. Currently, 0.2% of the company’s stock are sold short. Currently, 0.2% of the company’s stock are sold short. Based on an average daily volume of 6,248 shares, the short-interest ratio is presently 0.4 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Click in a research note on Monday, December 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Click Price Performance

Shares of NASDAQ CLIK traded down $0.15 during mid-day trading on Friday, hitting $3.43. The stock had a trading volume of 8,881 shares, compared to its average volume of 6,345. The company has a 50 day moving average of $5.03 and a two-hundred day moving average of $7.25. Click has a twelve month low of $3.10 and a twelve month high of $102.90.

About Click

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.